About David Weisman MD
Dr. Weisman’s research focuses on clinical trials for the prevention and treatment of Alzheimer’s disease, mild cognitive impairment, and other dementias. The site also has helped develop and test biomarkers in Alzheimer’s disease and advance novel treatments in other conditions such as stroke, Parkinson’s disease, multiple sclerosis, and pain. Dr. Weisman lectures on dementia and is a proponent of an early diagnosis and better therapies for Alzheimer’s disease. He invented, developed, and validated the Philadelphia Cognitive Exam, a computerized cognitive test and expert screening system to diagnose and detect dementia.
​
Dr. Weisman has devoted his research career towards advancing new therapies in Alzheimer’s disease and devotes his clinical time to memory and cognitive problems. The trial center also advances treatments in stroke, multiple sclerosis, and Parkinson’s disease. He has been featured in the Philadelphia Inquirer for fighting on behalf of his patients. Dr. Weisman has published numerous scientific articles and abstracts. In the popular press, published pieces include Seed Magazine on Buddhism, Chronic Traumatic Encephalopathy and football, and the mind. His technical scientific papers appear in the journals Neurology, Archives of Neurology, Stroke and Seminars in Neurology. His Alzheimer trial work collaborations have been published in Neurology, New England Journal of Medicine, and Archives of Neurology.
Education
Medical School - Pennsylvania State College of Medicine
Residency in Neurology - Yale New Haven Hospital
Fellowship in Alzheimer's disease and other dementias - University of California, San Diego